| Primary |
| Glaucoma |
51.9% |
| Drug Use For Unknown Indication |
13.9% |
| Product Used For Unknown Indication |
8.2% |
| Intraocular Pressure Increased |
6.9% |
| Hypertension |
5.6% |
| Blood Cholesterol Increased |
1.9% |
| Dry Eye |
1.7% |
| Intraocular Pressure Test |
1.4% |
| Blood Pressure |
1.3% |
| Open Angle Glaucoma |
1.1% |
| Diabetes Mellitus |
1.0% |
| Hypothyroidism |
1.0% |
| Postoperative Care |
0.6% |
| Thyroid Disorder |
0.6% |
| Ocular Hypertension |
0.5% |
| Osteoporosis |
0.5% |
| Pain |
0.5% |
| Abnormal Sensation In Eye |
0.5% |
| Borderline Glaucoma |
0.4% |
| Breast Cancer |
0.4% |
|
| Ocular Hyperaemia |
21.0% |
| Vision Blurred |
15.3% |
| Eye Irritation |
7.3% |
| Somnolence |
5.6% |
| Dizziness |
5.4% |
| Fatigue |
5.4% |
| Eye Pain |
5.1% |
| Hypotension |
5.1% |
| Dry Mouth |
3.2% |
| Eye Pruritus |
3.2% |
| Dyspnoea |
3.0% |
| Headache |
2.7% |
| Visual Acuity Reduced |
2.7% |
| Lacrimation Increased |
2.4% |
| Bradycardia |
2.2% |
| Hypersensitivity |
2.2% |
| Intraocular Pressure Increased |
2.2% |
| Swelling Face |
2.2% |
| Urticaria |
2.2% |
| Erythema Of Eyelid |
1.9% |
|
| Secondary |
| Glaucoma |
29.9% |
| Intraocular Pressure Increased |
16.1% |
| Hypertension |
8.2% |
| Product Used For Unknown Indication |
8.2% |
| Cardiac Disorder |
4.0% |
| Dry Eye |
4.0% |
| Blood Cholesterol Increased |
3.4% |
| Open Angle Glaucoma |
3.4% |
| Pain |
2.8% |
| Breast Cancer |
2.5% |
| Intraocular Pressure Test |
2.3% |
| Ocular Hypertension |
2.3% |
| Prophylaxis |
2.0% |
| Scleritis |
2.0% |
| Blood Triglycerides Increased |
1.7% |
| Drug Use For Unknown Indication |
1.7% |
| Post Procedural Complication |
1.7% |
| Diabetes Mellitus |
1.4% |
| Postoperative Care |
1.4% |
| Blood Pressure |
1.1% |
|
| Ocular Hyperaemia |
17.9% |
| Intraocular Pressure Increased |
10.3% |
| Therapeutic Response Unexpected |
9.0% |
| Corneal Disorder |
5.1% |
| Malaise |
5.1% |
| Palpitations |
5.1% |
| Vision Blurred |
5.1% |
| Eye Irritation |
3.8% |
| Eye Pain |
3.8% |
| Eye Pruritus |
3.8% |
| Muscular Weakness |
3.8% |
| Somnolence |
3.8% |
| Ulcerative Keratitis |
3.8% |
| Visual Acuity Reduced |
3.8% |
| Asthma |
2.6% |
| Dizziness |
2.6% |
| Drug Ineffective |
2.6% |
| Fatigue |
2.6% |
| Inappropriate Schedule Of Drug Administration |
2.6% |
| Pregnancy |
2.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
26.6% |
| Glaucoma |
24.4% |
| Drug Use For Unknown Indication |
9.3% |
| Hypertension |
6.6% |
| Rheumatoid Arthritis |
3.7% |
| Diabetes Mellitus |
3.5% |
| Blood Cholesterol Increased |
2.8% |
| Type 2 Diabetes Mellitus |
2.7% |
| Cardiac Disorder |
2.3% |
| Depression |
2.0% |
| Pain |
2.0% |
| Gastrooesophageal Reflux Disease |
1.9% |
| Atrial Fibrillation |
1.8% |
| Blood Pressure Increased |
1.6% |
| Bone Disorder |
1.6% |
| Scleritis |
1.6% |
| Crohn's Disease |
1.5% |
| Eye Disorder |
1.5% |
| Dry Eye |
1.4% |
| Intraocular Pressure Increased |
1.4% |
|
| Visual Impairment |
13.0% |
| Ocular Hyperaemia |
8.1% |
| Vision Blurred |
6.8% |
| Glaucoma |
6.2% |
| Visual Acuity Reduced |
6.2% |
| Weight Decreased |
6.2% |
| Death |
5.6% |
| Off Label Use |
5.6% |
| Intraocular Pressure Increased |
4.3% |
| Pain |
4.3% |
| Cardiac Arrest |
3.7% |
| Small Intestinal Obstruction |
3.7% |
| Vomiting |
3.7% |
| Weight Increased |
3.7% |
| Drug Ineffective |
3.1% |
| Myalgia |
3.1% |
| Nausea |
3.1% |
| Nervousness |
3.1% |
| Photophobia |
3.1% |
| Rash |
3.1% |
|
| Interacting |
| Glaucoma |
40.0% |
| Arrhythmia |
20.0% |
| Atrial Fibrillation |
20.0% |
| Hyperthyroidism |
20.0% |
|
|
